FDA ad­comm votes in fa­vor of ap­prov­ing Proven­tion Bio’s drug to de­lay type 1 di­a­betes

Fol­low­ing heat­ed dis­cus­sions on the small but pos­i­tive piv­otal tri­al, the FDA’s En­docrino­log­ic and Meta­bol­ic Drugs Ad­vi­so­ry Com­mit­tee on Thurs­day vot­ed 10-7 in fa­vor of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER